Effectiveness of the Ad26.COV2.S (Johnson & Johnson) Coronavirus Disease 2019 (COVID-19) Vaccine for Preventing COVID-19 Hospitalizations and Progression to High Disease Severity in the United States
Pharmacology, Toxicology and Pharmaceutical Science
1
2%
Agricultural and Biological Sciences
1
2%
Other
0
0%
Unknown
27
63%
Attention Score in Context
Attention Score in Context
This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 October 2022.
All research outputs
#8,109,434
of 28,110,440 outputs
Outputs from Clinical Infectious Diseases
#10,506
of 18,642 outputs
Outputs of similar age
#136,913
of 456,210 outputs
Outputs of similar age from Clinical Infectious Diseases
#145
of 239 outputs
Altmetric has tracked 28,110,440 research outputs across all sources so far. This one has received more attention than most of these and is in the 70th percentile.
So far Altmetric has tracked 18,642 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 30.7. This one is in the 43rd percentile – i.e., 43% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 456,210 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 69% of its contemporaries.
We're also able to compare this research output to 239 others from the same source and published within six weeks on either side of this one. This one is in the 38th percentile – i.e., 38% of its contemporaries scored the same or lower than it.
